Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Richard Chapman who wrote (1536)	9/1/2000 8:19:29 AM
From: scott_jiminez	Respond to of 52153

Thanks Richard. A SNP is a single base pair 'difference' found in a gene, its flanking sequences, or in modulation domains in a subpopulation of individuals. These polymorphisms have attracted substantial attention because of their possible correlation to disease. An offshoot of SNP discovery, among many others, is differential drug response/resistance.

To: Richard Chapman who wrote (1536)	9/1/2000 6:08:17 PM
From: Russ B	Respond to of 52153

Very interesting Richard, thanks.. I printed this out to put in my collection of reading.. DNAP released a PR today, you may want to read it too.. I am very interested in the genome evolution, and you will see me here and there as a DD companies..I feel DNAP is a true ground floor company, that's why I'm in.. Risky, but after getting the investor's package I'm very long.. Good luck, have a great weekend.. BTW, word is that DNAP is sitting on some huge news, a strategic alliance with a big bio player, we shall see!